Global Cyazofamid Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Cyazofamid market size is predicted to grow from US$ 114 million in 2025 to US$ 127 million in 2031; it is expected to grow at a CAGR of 1.9% from 2025 to 2031.
Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.
Cyazofamid has good toxicological, environmental and ecotoxicological profiles.
In this report, we count technical grade and chapter 6 displays the preparation content.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, with the share of 81%.
The consumption shares of Japan, China, North America and Europe were 42%, 21%, 17% and 11%. Japan is the main import region and other countries need to import from Japan.
LP Information, Inc. (LPI) ' newest research report, the “Cyazofamid Industry Forecast” looks at past sales and reviews total world Cyazofamid sales in 2024, providing a comprehensive analysis by region and market sector of projected Cyazofamid sales for 2025 through 2031. With Cyazofamid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyazofamid industry.
This Insight Report provides a comprehensive analysis of the global Cyazofamid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyazofamid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyazofamid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyazofamid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyazofamid.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyazofamid market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Cyazofamid market?
What factors are driving Cyazofamid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyazofamid market opportunities vary by end market size?
How does Cyazofamid break out by Type, by Application?
The global Cyazofamid market size is predicted to grow from US$ 114 million in 2025 to US$ 127 million in 2031; it is expected to grow at a CAGR of 1.9% from 2025 to 2031.
Cyazofamid is a kind of sulfamethoxazole fungicides with light yellow solid powder, which has high biological activity against the fungi.
Cyazofamid, discovered and developed by ISHIHARA SANGYO KAISHA on the global basis after first launched in 2001, is often used in downy mildew, oomycetes diseases, pepper and others.
Cyazofamid has good toxicological, environmental and ecotoxicological profiles.
In this report, we count technical grade and chapter 6 displays the preparation content.
ISHIHARA SANGYO KAISHA is the largest manufacturer in the global market, with the share of 81%.
The consumption shares of Japan, China, North America and Europe were 42%, 21%, 17% and 11%. Japan is the main import region and other countries need to import from Japan.
LP Information, Inc. (LPI) ' newest research report, the “Cyazofamid Industry Forecast” looks at past sales and reviews total world Cyazofamid sales in 2024, providing a comprehensive analysis by region and market sector of projected Cyazofamid sales for 2025 through 2031. With Cyazofamid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyazofamid industry.
This Insight Report provides a comprehensive analysis of the global Cyazofamid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyazofamid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyazofamid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyazofamid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyazofamid.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyazofamid market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Agriculture Grade
- Others
- Downy Mildew
- Oomycetes Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ISHIHARA SANGYO KAISHA
- Rudong Zhongyi
What is the 10-year outlook for the global Cyazofamid market?
What factors are driving Cyazofamid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyazofamid market opportunities vary by end market size?
How does Cyazofamid break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cyazofamid Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cyazofamid by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cyazofamid by Country/Region, 2020, 2024 & 2031
2.2 Cyazofamid Segment by Type
2.2.1 Agriculture Grade
2.2.2 Others
2.3 Cyazofamid Sales by Type
2.3.1 Global Cyazofamid Sales Market Share by Type (2020-2025)
2.3.2 Global Cyazofamid Revenue and Market Share by Type (2020-2025)
2.3.3 Global Cyazofamid Sale Price by Type (2020-2025)
2.4 Cyazofamid Segment by Application
2.4.1 Downy Mildew
2.4.2 Oomycetes Diseases
2.4.3 Others
2.5 Cyazofamid Sales by Application
2.5.1 Global Cyazofamid Sale Market Share by Application (2020-2025)
2.5.2 Global Cyazofamid Revenue and Market Share by Application (2020-2025)
2.5.3 Global Cyazofamid Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Cyazofamid Breakdown Data by Company
3.1.1 Global Cyazofamid Annual Sales by Company (2020-2025)
3.1.2 Global Cyazofamid Sales Market Share by Company (2020-2025)
3.2 Global Cyazofamid Annual Revenue by Company (2020-2025)
3.2.1 Global Cyazofamid Revenue by Company (2020-2025)
3.2.2 Global Cyazofamid Revenue Market Share by Company (2020-2025)
3.3 Global Cyazofamid Sale Price by Company
3.4 Key Manufacturers Cyazofamid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyazofamid Product Location Distribution
3.4.2 Players Cyazofamid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CYAZOFAMID BY GEOGRAPHIC REGION
4.1 World Historic Cyazofamid Market Size by Geographic Region (2020-2025)
4.1.1 Global Cyazofamid Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cyazofamid Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cyazofamid Market Size by Country/Region (2020-2025)
4.2.1 Global Cyazofamid Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cyazofamid Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cyazofamid Sales Growth
4.4 APAC Cyazofamid Sales Growth
4.5 Europe Cyazofamid Sales Growth
4.6 Middle East & Africa Cyazofamid Sales Growth
5 AMERICAS
5.1 Americas Cyazofamid Sales by Country
5.1.1 Americas Cyazofamid Sales by Country (2020-2025)
5.1.2 Americas Cyazofamid Revenue by Country (2020-2025)
5.2 Americas Cyazofamid Sales by Type (2020-2025)
5.3 Americas Cyazofamid Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyazofamid Sales by Region
6.1.1 APAC Cyazofamid Sales by Region (2020-2025)
6.1.2 APAC Cyazofamid Revenue by Region (2020-2025)
6.2 APAC Cyazofamid Sales by Type (2020-2025)
6.3 APAC Cyazofamid Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cyazofamid by Country
7.1.1 Europe Cyazofamid Sales by Country (2020-2025)
7.1.2 Europe Cyazofamid Revenue by Country (2020-2025)
7.2 Europe Cyazofamid Sales by Type (2020-2025)
7.3 Europe Cyazofamid Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cyazofamid by Country
8.1.1 Middle East & Africa Cyazofamid Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cyazofamid Revenue by Country (2020-2025)
8.2 Middle East & Africa Cyazofamid Sales by Type (2020-2025)
8.3 Middle East & Africa Cyazofamid Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyazofamid
10.3 Manufacturing Process Analysis of Cyazofamid
10.4 Industry Chain Structure of Cyazofamid
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyazofamid Distributors
11.3 Cyazofamid Customer
12 WORLD FORECAST REVIEW FOR CYAZOFAMID BY GEOGRAPHIC REGION
12.1 Global Cyazofamid Market Size Forecast by Region
12.1.1 Global Cyazofamid Forecast by Region (2026-2031)
12.1.2 Global Cyazofamid Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cyazofamid Forecast by Type (2026-2031)
12.7 Global Cyazofamid Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 ISHIHARA SANGYO KAISHA
13.1.1 ISHIHARA SANGYO KAISHA Company Information
13.1.2 ISHIHARA SANGYO KAISHA Cyazofamid Product Portfolios and Specifications
13.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ISHIHARA SANGYO KAISHA Main Business Overview
13.1.5 ISHIHARA SANGYO KAISHA Latest Developments
13.2 Rudong Zhongyi
13.2.1 Rudong Zhongyi Company Information
13.2.2 Rudong Zhongyi Cyazofamid Product Portfolios and Specifications
13.2.3 Rudong Zhongyi Cyazofamid Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Rudong Zhongyi Main Business Overview
13.2.5 Rudong Zhongyi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Cyazofamid Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Cyazofamid Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Agriculture Grade
Table 4. Major Players of Others
Table 5. Global Cyazofamid Sales byType (2020-2025) & (K MT)
Table 6. Global Cyazofamid Sales Market Share byType (2020-2025)
Table 7. Global Cyazofamid Revenue byType (2020-2025) & ($ million)
Table 8. Global Cyazofamid Revenue Market Share byType (2020-2025)
Table 9. Global Cyazofamid Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Cyazofamid Sale by Application (2020-2025) & (K MT)
Table 11. Global Cyazofamid Sale Market Share by Application (2020-2025)
Table 12. Global Cyazofamid Revenue by Application (2020-2025) & ($ million)
Table 13. Global Cyazofamid Revenue Market Share by Application (2020-2025)
Table 14. Global Cyazofamid Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Cyazofamid Sales by Company (2020-2025) & (K MT)
Table 16. Global Cyazofamid Sales Market Share by Company (2020-2025)
Table 17. Global Cyazofamid Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Cyazofamid Revenue Market Share by Company (2020-2025)
Table 19. Global Cyazofamid Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Cyazofamid Producing Area Distribution and Sales Area
Table 21. Players Cyazofamid Products Offered
Table 22. Cyazofamid Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Cyazofamid Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Cyazofamid Sales Market Share Geographic Region (2020-2025)
Table 27. Global Cyazofamid Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Cyazofamid Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Cyazofamid Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Cyazofamid Sales Market Share by Country/Region (2020-2025)
Table 31. Global Cyazofamid Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Cyazofamid Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Cyazofamid Sales by Country (2020-2025) & (K MT)
Table 34. Americas Cyazofamid Sales Market Share by Country (2020-2025)
Table 35. Americas Cyazofamid Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Cyazofamid Sales byType (2020-2025) & (K MT)
Table 37. Americas Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 38. APAC Cyazofamid Sales by Region (2020-2025) & (K MT)
Table 39. APAC Cyazofamid Sales Market Share by Region (2020-2025)
Table 40. APAC Cyazofamid Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Cyazofamid Sales byType (2020-2025) & (K MT)
Table 42. APAC Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 43. Europe Cyazofamid Sales by Country (2020-2025) & (K MT)
Table 44. Europe Cyazofamid Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Cyazofamid Sales byType (2020-2025) & (K MT)
Table 46. Europe Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Cyazofamid Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Cyazofamid Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Cyazofamid Sales byType (2020-2025) & (K MT)
Table 50. Middle East & Africa Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Cyazofamid
Table 52. Key Market Challenges & Risks of Cyazofamid
Table 53. Key IndustryTrends of Cyazofamid
Table 54. Cyazofamid Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Cyazofamid Distributors List
Table 57. Cyazofamid Customer List
Table 58. Global Cyazofamid SalesForecast by Region (2026-2031) & (K MT)
Table 59. Global Cyazofamid RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Cyazofamid SalesForecast by Country (2026-2031) & (K MT)
Table 61. Americas Cyazofamid Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Cyazofamid SalesForecast by Region (2026-2031) & (K MT)
Table 63. APAC Cyazofamid Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Cyazofamid SalesForecast by Country (2026-2031) & (K MT)
Table 65. Europe Cyazofamid RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Cyazofamid SalesForecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Cyazofamid RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Cyazofamid SalesForecast byType (2026-2031) & (K MT)
Table 69. Global Cyazofamid RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Cyazofamid SalesForecast by Application (2026-2031) & (K MT)
Table 71. Global Cyazofamid RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. ISHIHARA SANGYO KAISHA Basic Information, Cyazofamid Manufacturing Base, Sales Area and Its Competitors
Table 73. ISHIHARA SANGYO KAISHA Cyazofamid Product Portfolios and Specifications
Table 74. ISHIHARA SANGYO KAISHA Cyazofamid Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. ISHIHARA SANGYO KAISHA Main Business
Table 76. ISHIHARA SANGYO KAISHA Latest Developments
Table 77. Rudong Zhongyi Basic Information, Cyazofamid Manufacturing Base, Sales Area and Its Competitors
Table 78. Rudong Zhongyi Cyazofamid Product Portfolios and Specifications
Table 79. Rudong Zhongyi Cyazofamid Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Rudong Zhongyi Main Business
Table 81. Rudong Zhongyi Latest Developments
LIST OFFIGURES
Figure 1. Picture of Cyazofamid
Figure 2. Cyazofamid Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyazofamid Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Cyazofamid Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Cyazofamid Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Cyazofamid Sales Market Share by Country/Region (2024)
Figure 10. Cyazofamid Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Agriculture Grade
Figure 12. Product Picture of Others
Figure 13. Global Cyazofamid Sales Market Share byType in 2025
Figure 14. Global Cyazofamid Revenue Market Share byType (2020-2025)
Figure 15. Cyazofamid Consumed in Downy Mildew
Figure 16. Global Cyazofamid Market: Downy Mildew (2020-2025) & (K MT)
Figure 17. Cyazofamid Consumed in Oomycetes Diseases
Figure 18. Global Cyazofamid Market: Oomycetes Diseases (2020-2025) & (K MT)
Figure 19. Cyazofamid Consumed in Others
Figure 20. Global Cyazofamid Market: Others (2020-2025) & (K MT)
Figure 21. Global Cyazofamid Sale Market Share by Application (2024)
Figure 22. Global Cyazofamid Revenue Market Share by Application in 2025
Figure 23. Cyazofamid Sales by Company in 2025 (K MT)
Figure 24. Global Cyazofamid Sales Market Share by Company in 2025
Figure 25. Cyazofamid Revenue by Company in 2025 ($ millions)
Figure 26. Global Cyazofamid Revenue Market Share by Company in 2025
Figure 27. Global Cyazofamid Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Cyazofamid Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Cyazofamid Sales 2020-2025 (K MT)
Figure 30. Americas Cyazofamid Revenue 2020-2025 ($ millions)
Figure 31. APAC Cyazofamid Sales 2020-2025 (K MT)
Figure 32. APAC Cyazofamid Revenue 2020-2025 ($ millions)
Figure 33. Europe Cyazofamid Sales 2020-2025 (K MT)
Figure 34. Europe Cyazofamid Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Cyazofamid Sales 2020-2025 (K MT)
Figure 36. Middle East & Africa Cyazofamid Revenue 2020-2025 ($ millions)
Figure 37. Americas Cyazofamid Sales Market Share by Country in 2025
Figure 38. Americas Cyazofamid Revenue Market Share by Country (2020-2025)
Figure 39. Americas Cyazofamid Sales Market Share byType (2020-2025)
Figure 40. Americas Cyazofamid Sales Market Share by Application (2020-2025)
Figure 41. United States Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Cyazofamid Sales Market Share by Region in 2025
Figure 46. APAC Cyazofamid Revenue Market Share by Region (2020-2025)
Figure 47. APAC Cyazofamid Sales Market Share byType (2020-2025)
Figure 48. APAC Cyazofamid Sales Market Share by Application (2020-2025)
Figure 49. China Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 53. India Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Cyazofamid Sales Market Share by Country in 2025
Figure 57. Europe Cyazofamid Revenue Market Share by Country (2020-2025)
Figure 58. Europe Cyazofamid Sales Market Share byType (2020-2025)
Figure 59. Europe Cyazofamid Sales Market Share by Application (2020-2025)
Figure 60. Germany Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 61.France Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Cyazofamid Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Cyazofamid Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Cyazofamid Sales Market Share by Application (2020-2025)
Figure 68. Egypt Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Cyazofamid in 2025
Figure 74. Manufacturing Process Analysis of Cyazofamid
Figure 75. Industry Chain Structure of Cyazofamid
Figure 76. Channels of Distribution
Figure 77. Global Cyazofamid Sales MarketForecast by Region (2026-2031)
Figure 78. Global Cyazofamid Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Cyazofamid Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Cyazofamid Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Cyazofamid Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Cyazofamid Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cyazofamid Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cyazofamid by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cyazofamid by Country/Region, 2020, 2024 & 2031
2.2 Cyazofamid Segment by Type
2.2.1 Agriculture Grade
2.2.2 Others
2.3 Cyazofamid Sales by Type
2.3.1 Global Cyazofamid Sales Market Share by Type (2020-2025)
2.3.2 Global Cyazofamid Revenue and Market Share by Type (2020-2025)
2.3.3 Global Cyazofamid Sale Price by Type (2020-2025)
2.4 Cyazofamid Segment by Application
2.4.1 Downy Mildew
2.4.2 Oomycetes Diseases
2.4.3 Others
2.5 Cyazofamid Sales by Application
2.5.1 Global Cyazofamid Sale Market Share by Application (2020-2025)
2.5.2 Global Cyazofamid Revenue and Market Share by Application (2020-2025)
2.5.3 Global Cyazofamid Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Cyazofamid Breakdown Data by Company
3.1.1 Global Cyazofamid Annual Sales by Company (2020-2025)
3.1.2 Global Cyazofamid Sales Market Share by Company (2020-2025)
3.2 Global Cyazofamid Annual Revenue by Company (2020-2025)
3.2.1 Global Cyazofamid Revenue by Company (2020-2025)
3.2.2 Global Cyazofamid Revenue Market Share by Company (2020-2025)
3.3 Global Cyazofamid Sale Price by Company
3.4 Key Manufacturers Cyazofamid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyazofamid Product Location Distribution
3.4.2 Players Cyazofamid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CYAZOFAMID BY GEOGRAPHIC REGION
4.1 World Historic Cyazofamid Market Size by Geographic Region (2020-2025)
4.1.1 Global Cyazofamid Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cyazofamid Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cyazofamid Market Size by Country/Region (2020-2025)
4.2.1 Global Cyazofamid Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cyazofamid Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cyazofamid Sales Growth
4.4 APAC Cyazofamid Sales Growth
4.5 Europe Cyazofamid Sales Growth
4.6 Middle East & Africa Cyazofamid Sales Growth
5 AMERICAS
5.1 Americas Cyazofamid Sales by Country
5.1.1 Americas Cyazofamid Sales by Country (2020-2025)
5.1.2 Americas Cyazofamid Revenue by Country (2020-2025)
5.2 Americas Cyazofamid Sales by Type (2020-2025)
5.3 Americas Cyazofamid Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyazofamid Sales by Region
6.1.1 APAC Cyazofamid Sales by Region (2020-2025)
6.1.2 APAC Cyazofamid Revenue by Region (2020-2025)
6.2 APAC Cyazofamid Sales by Type (2020-2025)
6.3 APAC Cyazofamid Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cyazofamid by Country
7.1.1 Europe Cyazofamid Sales by Country (2020-2025)
7.1.2 Europe Cyazofamid Revenue by Country (2020-2025)
7.2 Europe Cyazofamid Sales by Type (2020-2025)
7.3 Europe Cyazofamid Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cyazofamid by Country
8.1.1 Middle East & Africa Cyazofamid Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cyazofamid Revenue by Country (2020-2025)
8.2 Middle East & Africa Cyazofamid Sales by Type (2020-2025)
8.3 Middle East & Africa Cyazofamid Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyazofamid
10.3 Manufacturing Process Analysis of Cyazofamid
10.4 Industry Chain Structure of Cyazofamid
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyazofamid Distributors
11.3 Cyazofamid Customer
12 WORLD FORECAST REVIEW FOR CYAZOFAMID BY GEOGRAPHIC REGION
12.1 Global Cyazofamid Market Size Forecast by Region
12.1.1 Global Cyazofamid Forecast by Region (2026-2031)
12.1.2 Global Cyazofamid Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cyazofamid Forecast by Type (2026-2031)
12.7 Global Cyazofamid Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 ISHIHARA SANGYO KAISHA
13.1.1 ISHIHARA SANGYO KAISHA Company Information
13.1.2 ISHIHARA SANGYO KAISHA Cyazofamid Product Portfolios and Specifications
13.1.3 ISHIHARA SANGYO KAISHA Cyazofamid Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ISHIHARA SANGYO KAISHA Main Business Overview
13.1.5 ISHIHARA SANGYO KAISHA Latest Developments
13.2 Rudong Zhongyi
13.2.1 Rudong Zhongyi Company Information
13.2.2 Rudong Zhongyi Cyazofamid Product Portfolios and Specifications
13.2.3 Rudong Zhongyi Cyazofamid Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Rudong Zhongyi Main Business Overview
13.2.5 Rudong Zhongyi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Cyazofamid Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Cyazofamid Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Agriculture Grade
Table 4. Major Players of Others
Table 5. Global Cyazofamid Sales byType (2020-2025) & (K MT)
Table 6. Global Cyazofamid Sales Market Share byType (2020-2025)
Table 7. Global Cyazofamid Revenue byType (2020-2025) & ($ million)
Table 8. Global Cyazofamid Revenue Market Share byType (2020-2025)
Table 9. Global Cyazofamid Sale Price byType (2020-2025) & (USD/MT)
Table 10. Global Cyazofamid Sale by Application (2020-2025) & (K MT)
Table 11. Global Cyazofamid Sale Market Share by Application (2020-2025)
Table 12. Global Cyazofamid Revenue by Application (2020-2025) & ($ million)
Table 13. Global Cyazofamid Revenue Market Share by Application (2020-2025)
Table 14. Global Cyazofamid Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Cyazofamid Sales by Company (2020-2025) & (K MT)
Table 16. Global Cyazofamid Sales Market Share by Company (2020-2025)
Table 17. Global Cyazofamid Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Cyazofamid Revenue Market Share by Company (2020-2025)
Table 19. Global Cyazofamid Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Cyazofamid Producing Area Distribution and Sales Area
Table 21. Players Cyazofamid Products Offered
Table 22. Cyazofamid Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Cyazofamid Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Cyazofamid Sales Market Share Geographic Region (2020-2025)
Table 27. Global Cyazofamid Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Cyazofamid Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Cyazofamid Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Cyazofamid Sales Market Share by Country/Region (2020-2025)
Table 31. Global Cyazofamid Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Cyazofamid Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Cyazofamid Sales by Country (2020-2025) & (K MT)
Table 34. Americas Cyazofamid Sales Market Share by Country (2020-2025)
Table 35. Americas Cyazofamid Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Cyazofamid Sales byType (2020-2025) & (K MT)
Table 37. Americas Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 38. APAC Cyazofamid Sales by Region (2020-2025) & (K MT)
Table 39. APAC Cyazofamid Sales Market Share by Region (2020-2025)
Table 40. APAC Cyazofamid Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Cyazofamid Sales byType (2020-2025) & (K MT)
Table 42. APAC Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 43. Europe Cyazofamid Sales by Country (2020-2025) & (K MT)
Table 44. Europe Cyazofamid Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Cyazofamid Sales byType (2020-2025) & (K MT)
Table 46. Europe Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Cyazofamid Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Cyazofamid Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Cyazofamid Sales byType (2020-2025) & (K MT)
Table 50. Middle East & Africa Cyazofamid Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Cyazofamid
Table 52. Key Market Challenges & Risks of Cyazofamid
Table 53. Key IndustryTrends of Cyazofamid
Table 54. Cyazofamid Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Cyazofamid Distributors List
Table 57. Cyazofamid Customer List
Table 58. Global Cyazofamid SalesForecast by Region (2026-2031) & (K MT)
Table 59. Global Cyazofamid RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Cyazofamid SalesForecast by Country (2026-2031) & (K MT)
Table 61. Americas Cyazofamid Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Cyazofamid SalesForecast by Region (2026-2031) & (K MT)
Table 63. APAC Cyazofamid Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Cyazofamid SalesForecast by Country (2026-2031) & (K MT)
Table 65. Europe Cyazofamid RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Cyazofamid SalesForecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Cyazofamid RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Cyazofamid SalesForecast byType (2026-2031) & (K MT)
Table 69. Global Cyazofamid RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Cyazofamid SalesForecast by Application (2026-2031) & (K MT)
Table 71. Global Cyazofamid RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. ISHIHARA SANGYO KAISHA Basic Information, Cyazofamid Manufacturing Base, Sales Area and Its Competitors
Table 73. ISHIHARA SANGYO KAISHA Cyazofamid Product Portfolios and Specifications
Table 74. ISHIHARA SANGYO KAISHA Cyazofamid Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. ISHIHARA SANGYO KAISHA Main Business
Table 76. ISHIHARA SANGYO KAISHA Latest Developments
Table 77. Rudong Zhongyi Basic Information, Cyazofamid Manufacturing Base, Sales Area and Its Competitors
Table 78. Rudong Zhongyi Cyazofamid Product Portfolios and Specifications
Table 79. Rudong Zhongyi Cyazofamid Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Rudong Zhongyi Main Business
Table 81. Rudong Zhongyi Latest Developments
LIST OFFIGURES
Figure 1. Picture of Cyazofamid
Figure 2. Cyazofamid Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyazofamid Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Cyazofamid Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Cyazofamid Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Cyazofamid Sales Market Share by Country/Region (2024)
Figure 10. Cyazofamid Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Agriculture Grade
Figure 12. Product Picture of Others
Figure 13. Global Cyazofamid Sales Market Share byType in 2025
Figure 14. Global Cyazofamid Revenue Market Share byType (2020-2025)
Figure 15. Cyazofamid Consumed in Downy Mildew
Figure 16. Global Cyazofamid Market: Downy Mildew (2020-2025) & (K MT)
Figure 17. Cyazofamid Consumed in Oomycetes Diseases
Figure 18. Global Cyazofamid Market: Oomycetes Diseases (2020-2025) & (K MT)
Figure 19. Cyazofamid Consumed in Others
Figure 20. Global Cyazofamid Market: Others (2020-2025) & (K MT)
Figure 21. Global Cyazofamid Sale Market Share by Application (2024)
Figure 22. Global Cyazofamid Revenue Market Share by Application in 2025
Figure 23. Cyazofamid Sales by Company in 2025 (K MT)
Figure 24. Global Cyazofamid Sales Market Share by Company in 2025
Figure 25. Cyazofamid Revenue by Company in 2025 ($ millions)
Figure 26. Global Cyazofamid Revenue Market Share by Company in 2025
Figure 27. Global Cyazofamid Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Cyazofamid Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Cyazofamid Sales 2020-2025 (K MT)
Figure 30. Americas Cyazofamid Revenue 2020-2025 ($ millions)
Figure 31. APAC Cyazofamid Sales 2020-2025 (K MT)
Figure 32. APAC Cyazofamid Revenue 2020-2025 ($ millions)
Figure 33. Europe Cyazofamid Sales 2020-2025 (K MT)
Figure 34. Europe Cyazofamid Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Cyazofamid Sales 2020-2025 (K MT)
Figure 36. Middle East & Africa Cyazofamid Revenue 2020-2025 ($ millions)
Figure 37. Americas Cyazofamid Sales Market Share by Country in 2025
Figure 38. Americas Cyazofamid Revenue Market Share by Country (2020-2025)
Figure 39. Americas Cyazofamid Sales Market Share byType (2020-2025)
Figure 40. Americas Cyazofamid Sales Market Share by Application (2020-2025)
Figure 41. United States Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Cyazofamid Sales Market Share by Region in 2025
Figure 46. APAC Cyazofamid Revenue Market Share by Region (2020-2025)
Figure 47. APAC Cyazofamid Sales Market Share byType (2020-2025)
Figure 48. APAC Cyazofamid Sales Market Share by Application (2020-2025)
Figure 49. China Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 53. India Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Cyazofamid Sales Market Share by Country in 2025
Figure 57. Europe Cyazofamid Revenue Market Share by Country (2020-2025)
Figure 58. Europe Cyazofamid Sales Market Share byType (2020-2025)
Figure 59. Europe Cyazofamid Sales Market Share by Application (2020-2025)
Figure 60. Germany Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 61.France Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Cyazofamid Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Cyazofamid Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Cyazofamid Sales Market Share by Application (2020-2025)
Figure 68. Egypt Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Cyazofamid Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Cyazofamid in 2025
Figure 74. Manufacturing Process Analysis of Cyazofamid
Figure 75. Industry Chain Structure of Cyazofamid
Figure 76. Channels of Distribution
Figure 77. Global Cyazofamid Sales MarketForecast by Region (2026-2031)
Figure 78. Global Cyazofamid Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Cyazofamid Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Cyazofamid Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Cyazofamid Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Cyazofamid Revenue Market ShareForecast by Application (2026-2031)
